• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤干细胞:肿瘤进展和复发的驱动因素。

Glioma stem cells: drivers of tumor progression and recurrence.

作者信息

He Jiaoyan, Yan Xiuwei, Hu Shaoshan

机构信息

Cancer Center, Department of Neurosurgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.

出版信息

Stem Cell Res Ther. 2025 Jun 7;16(1):293. doi: 10.1186/s13287-025-04352-z.

DOI:10.1186/s13287-025-04352-z
PMID:40483525
Abstract

Glioma, a common malignancy of the central nervous system, attracts significant clinical attention due to its poor prognosis. Glioma stem cells (GSCs), characterized by stem-like properties and substantial heterogeneity, play a crucial role in tumor initiation, progression, and potential recurrence. Moreover, through complex interaction mechanisms, they contribute to the challenges associated with treatment. This review seeks to explore the distinctive characteristics and underlying mechanisms of GSCs, aiming to provide novel theoretical insights and practical strategies for precision therapy in glioma.

摘要

胶质瘤是中枢神经系统常见的恶性肿瘤,因其预后较差而备受临床关注。胶质瘤干细胞(GSCs)具有干细胞样特性和显著的异质性,在肿瘤的起始、进展及潜在复发中起关键作用。此外,通过复杂的相互作用机制,它们给治疗带来了挑战。本综述旨在探讨胶质瘤干细胞的独特特征和潜在机制,为胶质瘤的精准治疗提供新的理论见解和实践策略。

相似文献

1
Glioma stem cells: drivers of tumor progression and recurrence.胶质瘤干细胞:肿瘤进展和复发的驱动因素。
Stem Cell Res Ther. 2025 Jun 7;16(1):293. doi: 10.1186/s13287-025-04352-z.
2
Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.胶质瘤干细胞在伴有恶性进展的复发性肿瘤中比在原发性肿瘤中更具侵袭性,并且二者都能在体外长期维持。
BMC Cancer. 2008 Oct 22;8:304. doi: 10.1186/1471-2407-8-304.
3
Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.在复发性胶质母细胞瘤模型中,通过治疗应激诱导的缺氧诱导因子信号通路使胶质瘤细胞去分化为胶质瘤干细胞样细胞
Mol Cancer Ther. 2016 Dec;15(12):3064-3076. doi: 10.1158/1535-7163.MCT-15-0675. Epub 2016 Oct 7.
4
Hunting glioblastoma recurrence: glioma stem cells as retrospective targets.追踪胶质母细胞瘤复发:胶质瘤干细胞作为回顾性靶点。
Am J Physiol Cell Physiol. 2025 Mar 1;328(3):C1045-C1061. doi: 10.1152/ajpcell.00344.2024. Epub 2025 Jan 16.
5
Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies.神经胶质瘤干细胞促进神经胶质瘤进展:分子途径和靶向治疗的系统评价。
Int J Mol Sci. 2024 Jul 22;25(14):7979. doi: 10.3390/ijms25147979.
6
MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.微小 RNA-30a 通过阻断 NT5E 依赖的 Akt 信号通路抑制神经胶质瘤干细胞的自我更新和致瘤性。
FASEB J. 2020 Apr;34(4):5128-5143. doi: 10.1096/fj.201802629RR. Epub 2020 Feb 17.
7
The role of glioma stem cells in glioma tumorigenesis.神经胶质瘤干细胞在神经胶质瘤肿瘤发生中的作用。
Front Biosci (Landmark Ed). 2014 Jan 1;19(5):818-24. doi: 10.2741/4249.
8
Targeting Glioma Stem Cells: Therapeutic Opportunities and Challenges.靶向胶质瘤干细胞:治疗机遇与挑战
Cells. 2025 May 6;14(9):675. doi: 10.3390/cells14090675.
9
Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells.长非编码 RNA(lncRNA)在神经胶质瘤干细胞中的功能作用。
Med Sci Monit. 2019 Oct 8;25:7567-7573. doi: 10.12659/MSM.916040.
10
Tumor vasculature and glioma stem cells: Contributions to glioma progression.肿瘤血管和神经胶质瘤干细胞:对神经胶质瘤进展的贡献。
Cancer Lett. 2016 Oct 1;380(2):545-551. doi: 10.1016/j.canlet.2014.12.028. Epub 2014 Dec 16.

引用本文的文献

1
Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential.羟基酪醇与脑肿瘤:作用机制及治疗潜力
Curr Issues Mol Biol. 2025 Aug 18;47(8):667. doi: 10.3390/cimb47080667.

本文引用的文献

1
Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer.SIRT1对胃癌中涉及H19-糖酵解-组蛋白乳酸化的正反馈环的去乳酸化酶作用。
Oncogene. 2025 Mar;44(11):724-738. doi: 10.1038/s41388-024-03243-6. Epub 2024 Dec 11.
2
FUS/circZEB1/miR-128-3p/LBH feedback loop contributes to the malignant phenotype of GSCs via TNF-α-mediated NF-κB signaling pathway.FUS/circZEB1/miR-128-3p/LBH反馈环通过肿瘤坏死因子-α介导的核因子-κB信号通路促进胶质瘤干细胞的恶性表型。
Cancer Cell Int. 2024 Nov 7;24(1):365. doi: 10.1186/s12935-024-03526-8.
3
Acidity induces durable enhancement of T cell suppressive functions for tumor immune evasion.
酸性诱导 T 细胞抑制功能的持久增强,以逃避肿瘤免疫。
Mol Immunol. 2024 Oct;174:57-68. doi: 10.1016/j.molimm.2024.08.004. Epub 2024 Aug 29.
4
Enhanced glycolysis causes extracellular acidification and activates acid-sensing ion channel 1a in hypoxic pulmonary hypertension.增强的糖酵解导致细胞外酸化,并在低氧性肺动脉高压中激活酸敏感离子通道 1a。
Am J Physiol Lung Cell Mol Physiol. 2024 Oct 1;327(4):L439-L451. doi: 10.1152/ajplung.00083.2024. Epub 2024 Aug 6.
5
100 years of the Warburg effect: A cancer metabolism endeavor.100 年的瓦堡效应:癌症代谢努力。
Cell. 2024 Jul 25;187(15):3824-3828. doi: 10.1016/j.cell.2024.06.026.
6
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.突变 IDH1 抑制诱导 dsDNA 感知以激活肿瘤免疫。
Science. 2024 Jul 12;385(6705):eadl6173. doi: 10.1126/science.adl6173.
7
Predicting blood-brain barrier permeability of molecules with a large language model and machine learning.利用大语言模型和机器学习预测分子的血脑屏障通透性。
Sci Rep. 2024 Jul 9;14(1):15844. doi: 10.1038/s41598-024-66897-y.
8
Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo.在体外和体内鉴定和表征针对 IL13Rα2 阳性人神经胶质瘤的新型 CAR-T 细胞。
Clin Transl Med. 2024 May;14(5):e1664. doi: 10.1002/ctm2.1664.
9
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma.DNA 低甲基化表型重塑受体酪氨酸激酶基因突变型神经胶质瘤中的谷氨酸能网络。
Acta Neuropathol Commun. 2024 Mar 13;12(1):40. doi: 10.1186/s40478-024-01750-x.
10
ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation.整合素α2(ITGA2)作为一种胶质瘤的预后因素,通过激活 STAT3 磷酸化促进 GSCs 侵袭和 EMT。
Carcinogenesis. 2024 Apr 12;45(4):235-246. doi: 10.1093/carcin/bgad096.